Methods of suppressing uv light-induced skin carcinogenesis
    7.
    发明申请
    Methods of suppressing uv light-induced skin carcinogenesis 审中-公开
    抑制紫外光诱导皮肤癌发生的方法

    公开(公告)号:US20090247477A1

    公开(公告)日:2009-10-01

    申请号:US11919430

    申请日:2006-04-27

    CPC分类号: A61K31/095

    摘要: Administration of the isothiocyanate protects against UV light-induced skin carcinogenesis. In particular, topical application or dietary administration of isothiocyanate sulforaphane after exposure to UV radiation provides effective protection against skin tumor formation. Sulforaphane analogs and glucosinolates also can be employed. Lotions useful for suppressing UV light-induced skin carcinogenesis also are provided.

    摘要翻译: 异硫氰酸盐的施用可防止紫外光诱导的皮肤癌发生。 特别地,在暴露于紫外线辐射后局部施用或异烟肼异硫氰酸酯萝卜硫素的饮食给予有效的防止皮肤肿瘤形成的保护。 也可以使用萝卜硫烷类似物和硫代葡萄糖苷。 还提供了用于抑制UV光诱导的皮肤致癌作用的乳液。

    Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
    8.
    发明授权
    Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes 有权
    预防和治疗谷胱甘肽和II期解毒酶的氧化应激障碍

    公开(公告)号:US07407986B2

    公开(公告)日:2008-08-05

    申请号:US10499196

    申请日:2002-12-18

    IPC分类号: A01N47/40

    摘要: The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathone or intracellular levels of at least one Phase II detoxification enzyme in animal tissue. The present invention also relates to the field of protecting a subject from oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathone or intracellular levels of at least one Phase II detoxification enzyme in the subject. The present invention also relates to a pharmaceutical composition useful for the treatment of oxidative stress disorders.

    摘要翻译: 本发明一般涉及通过施用药物有效量的提高动物组织中细胞内谷胱甘肽含量或细胞内水平的至少一种II期解毒酶的化合物来治疗氧化应激障碍的领域。 本发明还涉及通过施用药物有效量的提高受试者中的谷胱甘肽的细胞内水平或细胞内水平的至少一种II期解毒酶的化合物来保护受试者免受氧化应激障碍的领域。 本发明还涉及可用于治疗氧化应激障碍的药物组合物。